Escherichia coli cells harboring a non-attenuated trp-lac operon fusion were used to evaluate the effects of indolmycin on the initiation of transcription at the trp promoter. Indolmycin caused repression in trpR+ strains and in trpR deletion mutants, although higher effector concentrations were required in the latter situation. Plasmid-mediated elevation in tryptophanyl-tRNA synthetase reversed the inhibitory effect of indolmycin. Indolmycin did not facilitate the binding of purified Trp repressor protein to trp operator DNA.
Indolmycin, originally designated antibiotic PA155A (8, 12) , was isolated from a streptomycete subsequently identified as Streptomyces griseus (Krainsky) Waksman and Henrici sensu Pridham (13) . Elucidation of the structure of indolmycin (14) , supported by its complete chemical synthesis (10) , revealed the presence of an indole nucleus (Fig. 1) . Indeed, studies on the biosynthesis of indolmycin indicate that it is derived from tryptophan (6, 7). Detailed chemical studies have been performed on indolmycin, and its absolute configuration is known (2, 15) .
The first study of the mechanism of action of indolmycin revealed that it is a competitive inhibitor of tryptophanyl-tRNA synthetase of Escherichia coli (17) . Recent 
experiments have
shown that at least one class of E. coli mutant resistant to indolmycin has a tandem duplication of trpS, the structural gene for tryptophanyltRNA synthetase (R. Bryant, K. B. Low, and D. Soil, personal communication). Presumably, the increased trpS gene dosage leads to elevated intracellular levels of tryptophanyl-tRNA synthetase. Resistance to indolmycin in this case would be attributable to a specific increase in cellular capacity to aminoacylate tRNATrIp. The in vivo studies presented here with specially constructed E. coli strains largely confirm these findings. In addition, we have found that indolmycin can lead to a reduction in the expression of the trp operon by acting as a false corepressor.
A pair of essentially isogenic strains was utilized. NK5031 (Table 1) carries an intact trpR gene (the structural gene for Trp repressor), whereas SP361 has the entire trpR gene deleted. These strains were lysogenized with XGB2 (Table 1), a phage wherein the primary trp promot-er-operator (but no attenuator) is fused to lacZ, the structural gene for 3-galactosidase. Both NK5031 and SP361 are deleted for lacZ; thus, in XGB2 lysogens, the levels of 3-galactosidase reflect transcription initiated at the trp promoter. Repression by exogenous L-tryptophan in such strains conformed to the predicted pattern. The levels of 3-galactosidase in the strain capable of producing functional Trp repressor were reduced by a factor of 25 (from 3,980 to 160 units) when tryptophan was present (see the legend to Fig. 2 for the definition of units of 1-galactosidase). The strain deleted for trpR had 1-galactosidase levels after growth in media containing tryptophan (6,520 U) that were essentially indistinguishable from the values (6,470 U) obtained after cultivation in tryptophan-free media. Repression by exogenous tryptophan was not altered by the presence of a multicopy trpS+ plasmid.
A high-copy number plasmid, designated ptrpS13 (Table 1) , was constructed and introduced into each XGB2 lysogen. ptrpS13 is identical in all respects to pCH17 (5) , a plasmid for which nucleotide sequencing studies have confirmed the presence of the entire trpS gene (4) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of extracts of cells harboring ptrpS13 confirm that tryptophanyl-tRNA synthetase (monomer molecular weight, 37,000) is overproduced in these strains (C. Makaroff and R. Somerville, unpublished data). Strains harboring other plasmids similar to ptrpS13 exhibit levels of tryptophanyl-tRNA synthetase 55-fold higher than those in wild-type strains (J. Omnaas, M. Bonura, P. Chang, P. A. Safille, and K. trations of indolmycin (0.01 ,ug/ml) markedly decreased transcription from the trp promoter. When tryptophanyl-tRNA synthetase levels were elevated or when Trp repressor was absent, reductions in trp promoter utilization were observed only at high concentrations (>0.5 ,ug/ml) of indolmycin. Finally, when both tryptophanyl-tRNA synthetase levels were elevated and Trp repressor was absent, the trp promoter was completely unresponsive to very high levels of indolmycin. This was true even at 200 ,g of indolmycin per ml (data not shown).
All of the strains studied were totally unaffected with respect to growth rate over a range of indolmycin concentrations from 0 to 1.0 pug/ml. From 1.0 to 5.0 ,ug of indolmycin per ml, the strains harboring ptrpS13 were unaffected, but the non-plasmid-bearing strains exhibited a slight growth inhibition. Except for SP361(XGB2)(ptrpS13), the strains displayed marked sensitivity to levels of indolmycin above 5 ,g/ml.
The levels of ,-galactosidase in the four strains studied were essentially identical (plus or minus 7%) regardless of whether the assays were carried out on cultures entering stationary phase or involved differential rate determinations from cultures sampled during mid-log phase. For example, the relative activity of 1- galactosidase from a near-stationary phase culture of NK5031 (XGB2) in 0.01 jig of indolmycin per ml was 62% of the control value, whereas a differential rate analysis of mid-log phase cells gave a value of 65% of the control value (Fig. 2) .
In the presence of Trp repressor protein, indolmycin mediated repression of the trp promoter most effectively at a concentration of 1 ,ug/ml (Fig. 2) . At this level of indolmycin, 1B-galactosidase production in a trpR deletion was totally unaffected, whereas the activity in the trpR+ strain was nearly undetectable.
Tryptophan readily mediated the in vitro binding of Trp repressor protein to the trp operator, but indolmycin did not (Fig. 3) . Thus, a paradox seems to exist. In whole cells capable of making Trp repressor, indolmycin reduced transcription from the trp promoter, yet this compound failed to mediate in vitro the binding of Trp repressor to its primary DNA target.
The data in Fig. 2 Another possibility is that indolmycin-mediated inhibition of tryptophanyl-tRNA synthetase leads to increased intracellular levels of free tryptophan, thereby potentiating the activity of Trp repressor. Our finding that indolmycin-directed repression is specific for the trp operon and does not affect other known targets of Trp repressor, such as the trpR promoter, may not necessarily contradict this hypothesis. Trp repressor is known to have a higher affinity for the operator preceding the trp operon than for the operator preceding trpR (1) . This hypothesis fails to explain both the indolmycin-mediated increase in trp operon expression noted in trpR+ cells with elevated levels of tryptophanyl-tRNA synthetase and the decrease in trp operon expression that indolmycin can bring about in the absence of Trp repressor (Fig. 2) .
Finally, it is also conceivable that an indolmycin-tryptophanyl tRNA synthetase complex influences the initiation of transcription at the trp promoter (11) .
Clearly, the results presented here are not readily explained by current ideas about the control of transcription initiation at the trp promoter (18) . Indolmycin appears to specifically inhibit transcription from the trp promoter by mechanisms that are enhanced in trpR+ cells and countered by plasmid-mediated increases in intracellular tryptophanyl-tRNA synthetase. In addition, under certain conditions (Fig. 2) were in a total volume of 20 j.l containing 20 mM Trishydrochloride (pH 7.5), 10 mM MgCl2, 1 mM dithiothreitol, and 50 mM KCI. Indolmycin was added from a 4-mg/ml stock solution in dimethyl sulfoxide. After 30 min at 37°(, 1 U (1 ,lI) of HpaI (BRL) was added, and incubation continued for an additional 30 min. Products were separated on a 5% acrylamide gel. Lanes: (1) NOTES 1123 or stimulation. The trp-lacZ fusion employed in these studies was so constructed that the entire trp attenuator was absent. These results suggest a direct role for tryptophanyl-tRNA synthetase in the regulation of the trp operon in addition to its well-established indirect role in attenuation (18) . Elucidation of the mechanism of indolmycin-mediated alteration of transcription from the trp promoter may reveal unanticipated features of control in the trp system.
